Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros












Intervalo de año de publicación
1.
Amyloid ; 31(3): 209-219, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38973117

RESUMEN

BACKGROUND: Cardiac involvement in systemic light chain amyloidosis (AL) leads to chronic heart failure and is a major prognosis factor. Severe cellular defects are provoked in cardiac cells by tissue-deposited amyloid fibrils of misfolded free immunoglobulin light chains (LCs) and their prefibrillar oligomeric precursors. OBJECTIVE: Understanding the molecular mechanisms behind cardiac cell cytotoxicity is necessary to progress in therapy and to improve patient management. One key question is how extracellularly deposited molecules exert their toxic action inside cardiac cells. Here we searched for direct evidence of amyloid LC uptake by cardiomyocytes in patient biopsies. METHODS: We immunolocalized LCs in cardiac biopsies from four AL cardiac amyloidosis patients and analysed histopathological images by high resolution confocal microscopy and 3D image reconstruction. RESULTS: We show, for the first time directly in patient tissue, the presence of LCs inside cardiomyocytes, and report their proximity to nuclei and to caveolin-3-rich areas. Our observations point to macropinocytosis as a probable mechanism of LC uptake. CONCLUSIONS: Internalisation of LCs occurs in patient cardiomyocytes. This event could have important consequences for the pathogenesis of the cardiac disease by enabling interactions between amyloid molecules and cellular organelles inducing specific signalling pathways, and might bring new insight regarding treatment.


Asunto(s)
Cadenas Ligeras de Inmunoglobulina , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas , Miocitos Cardíacos , Humanos , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/patología , Cadenas Ligeras de Inmunoglobulina/metabolismo , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/metabolismo , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/patología , Biopsia , Masculino , Femenino , Persona de Mediana Edad , Anciano , Amiloide/metabolismo , Microscopía Confocal , Amiloidosis/metabolismo , Amiloidosis/patología , Amiloidosis/inmunología
2.
Adv Kidney Dis Health ; 31(4): 334-345, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39084759

RESUMEN

Amyloidosis is a complex group of rare disorders characterized by the deposition of misfolded proteins in the extracellular space of various tissues and organs, leading to progressive organ dysfunction. The kidneys constitute a very common site affected, most notably by immunoglobulin-mediated (light chain, heavy chain, and light and heavy chain amyloidosis), but other types that include serum amyloid A (AA) amyloidosis and leukocyte chemotactic factor 2 amyloidosis, along with mutant proteins in several hereditary forms of amyloidosis such as transthyretin, fibrinogen α-chain, gelsolin, lysozyme, and apolipoproteins AI/AII/AIV/CII/CIII amyloidosis have been incriminated as well. The clinical presentation is variable and can range from minimal proteinuria for leukocyte chemotactic factor 2 amyloidosis to a full-blown nephrotic syndrome for AA amyloidosis. Clinical correlation, genetic analysis, and adequate tissue typing through a kidney biopsy are essential to make the correct diagnosis, especially when a family history of amyloidosis is absent. Except for AA and transthyretin amyloidosis, the treatment is usually purely supportive. Kidney transplantation is an acceptable form of treatment for end-stage kidney disease in all types of non-Ig-mediated renal amyloidosis.


Asunto(s)
Amiloidosis , Humanos , Amiloidosis/diagnóstico , Amiloidosis/genética , Amiloidosis/inmunología , Amiloidosis/metabolismo , Enfermedades Renales/diagnóstico , Enfermedades Renales/patología , Enfermedades Renales/genética , Enfermedades Renales/etiología , Enfermedades Renales/metabolismo , Trasplante de Riñón , Riñón/patología , Riñón/metabolismo , Riñón/inmunología , Proteína Amiloide A Sérica
4.
J Neuroinflammation ; 21(1): 129, 2024 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-38745337

RESUMEN

Diet-induced increase in body weight is a growing health concern worldwide. Often accompanied by a low-grade metabolic inflammation that changes systemic functions, diet-induced alterations may contribute to neurodegenerative disorder progression as well. This study aims to non-invasively investigate diet-induced metabolic and inflammatory effects in the brain of an APPPS1 mouse model of Alzheimer's disease. [18F]FDG, [18F]FTHA, and [18F]GE-180 were used for in vivo PET imaging in wild-type and APPPS1 mice. Ex vivo flow cytometry and histology in brains complemented the in vivo findings. 1H- magnetic resonance spectroscopy in the liver, plasma metabolomics and flow cytometry of the white adipose tissue were used to confirm metaflammatory condition in the periphery. We found disrupted glucose and fatty acid metabolism after Western diet consumption, with only small regional changes in glial-dependent neuroinflammation in the brains of APPPS1 mice. Further ex vivo investigations revealed cytotoxic T cell involvement in the brains of Western diet-fed mice and a disrupted plasma metabolome. 1H-magentic resonance spectroscopy and immunological results revealed diet-dependent inflammatory-like misbalance in livers and fatty tissue. Our multimodal imaging study highlights the role of the brain-liver-fat axis and the adaptive immune system in the disruption of brain homeostasis in amyloid models of Alzheimer's disease.


Asunto(s)
Inmunidad Adaptativa , Amiloidosis , Encéfalo , Dieta Occidental , Modelos Animales de Enfermedad , Ratones Transgénicos , Animales , Ratones , Encéfalo/metabolismo , Encéfalo/patología , Encéfalo/diagnóstico por imagen , Encéfalo/inmunología , Amiloidosis/metabolismo , Amiloidosis/patología , Amiloidosis/inmunología , Dieta Occidental/efectos adversos , Ratones Endogámicos C57BL , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Enfermedad de Alzheimer/inmunología
5.
An. bras. dermatol ; 90(2): 270-271, Mar-Apr/2015. graf
Artículo en Inglés | LILACS | ID: lil-741075

RESUMEN

Immunoglobulin light chain amyloidosis is the most common acquired systemic amyloidosis. Its presentation is often insidious and progressive, which may delay diagnosis. The authors describe a rare case of immunoglobulin light chain amyloidosis in a 34-year-old man with scleroderma-like manifestation substantiated by multifarious laboratory investigations and the histopathologic feature of involved skin lesions stained with Congo red and crystal violet. This helps to maintain a high clinical suspicion of the disease when confronting similar skin presentation.


Asunto(s)
Humanos , Masculino , Adulto , Enfermedades de la Piel/patología , Cadenas Ligeras de Inmunoglobulina , Amiloidosis/patología , Piel/patología , Enfermedades de la Piel/inmunología , Síndrome , Biopsia , Citometría de Flujo , Amiloidosis/inmunología
6.
Rev. méd. hered ; 10(2): 43-44, jun. 1999.
Artículo en Español | LILACS, LIPECS | ID: biblio-1110961
7.
Arq. bras. oftalmol ; 53(1): 36-8, 1990. ilus
Artículo en Portugués | LILACS | ID: lil-117576

RESUMEN

Os autores apresentaram dois casos clinicamente distintos, com diagnóstico histopatológico de amiloidose corneana localizada, sem que padräo familiar e patologias oculares ou sistêmicas associadas pudessem ser identificadas. De acordo com a literatura, os autores fazem o diagnóstico de amiloidose corneana secundária, na qual a provável patologia causal näo foi identificada, mas näo descartam a possibilidade de amiloidose primária localizada da córnea, patologia esta extremamente rara


Asunto(s)
Adulto , Anciano , Masculino , Amiloidosis/inmunología , Córnea/anatomía & histología , Mieloma Múltiple/inmunología , Brasil
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...